91
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          T cell functional differentiation is mediated by lineage-specific transcription factors. T helper 17 (Th17) has been recently identified as a distinct Th lineage mediating tissue inflammation. Retinoic acid receptor-related orphan receptor gamma (ROR gamma) was shown to regulate Th17 differentiation; ROR gamma deficiency, however, did not completely abolish Th17 cytokine expression. Here, we report Th17 cells highly expressed another related nuclear receptor, ROR alpha, induced by transforming growth factor-beta and interleukin-6 (IL-6), which is dependent on signal transducer and activator of transcription 3. Overexpression of ROR alpha promoted Th17 differentiation, possibly through the conserved noncoding sequence 2 in Il17-Il17f locus. ROR alpha deficiency resulted in reduced IL-17 expression in vitro and in vivo. Furthermore, ROR alpha and ROR gamma coexpression synergistically led to greater Th17 differentiation. Double deficiencies in ROR alpha and ROR gamma globally impaired Th17 generation and completely protected mice against experimental autoimmune encephalomyelitis. Therefore, Th17 differentiation is directed by two lineage-specific nuclear receptors, ROR alpha and ROR gamma.

          Related collections

          Author and article information

          Journal
          Immunity
          Immunity
          Elsevier BV
          1074-7613
          1074-7613
          Jan 2008
          : 28
          : 1
          Affiliations
          [1 ] Department of Immunology, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
          Article
          S1074-7613(07)00575-4 NIHMS38562
          10.1016/j.immuni.2007.11.016
          2587175
          18164222
          fee4e1b7-ea00-4b39-b61a-2fa892d25c85
          History

          Comments

          Comment on this article